CordenPharma is the CDMO partner in supporting complex modalities for the advancement of the drug development lifecycle of Pharma- and Biotech companies. Harnessing the collective expertise of the teams across our globally integrated facility network, we provide bespoke outsourcing services spanning the complete supply chain, from early clinical-phase development to commercialization.
With scientific expertise and partnership at our core, we enable high-value, end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid NanoParticles (LNPs), sterile Injectables, and the extensive supply of Small Molecules (both Highly Potent and Regular Potency).